A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

British Journal of Clinical Pharmacology

Volumn 49, Issue 6, 2000, Pages 580-590

  Farmer, R D T ^a,c   Lawrenson, R A ^a   Todd, J C ^a   Williams, T J ^a   MacRae, K D ^d   Tyrer, F ^a   Leydon, G M ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Europ Inst of Hlth/Med Sciences   (United States)

^d NONE

Author keywords

Database studies; Oral contraceptives; Pill scare; Risk factors; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; DESOGESTREL; ESTRADIOL VALERATE PLUS NORGESTREL; ETHINYLESTRADIOL; GESTODENE; ORAL CONTRACEPTIVE AGENT;

AGE; ARTICLE; ASTHMA; BODY MASS; FEMALE; HUMAN; PRIORITY JOURNAL; RISK; SMOKING; VEIN THROMBOSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; DATABASES, FACTUAL; EPIDEMIOLOGIC STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; ODDS RATIO; PREGNANCY; PULMONARY EMBOLISM; REGRESSION ANALYSIS; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0034070719     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00198.x     Document Type: Article

References (19)

1. 1 Committee on the Safety of Medicines. Combined oral contraceptives and thromboembolism. London, Committee on the Safety of Medicines, 1995.
2. 2 Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet 1995; 346: 1589-1593.
3. 3 Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women Br Med J 1996; 312: 83-88.
4. 4 World Health Organization Collaborative study of cardiovascular disease and steroid hormone contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-1588.
5. 5 Lewis MA, Heinemann LAJ, MacRae KD, Bruppacher R, Spitzer WO. The increased risk of venous thromboembolism and the use of third generation progestogens: role of bias in observational research. Contraception 1996; 54: 5-13.
6. 6 Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiology, 1991; 133: 32-37.
7. 7 Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J Clin Res Ed 1986; 292: 526.
8. 8 Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 1987; 69: 91-95.
9. 9 Guillebaud J. Advising women on which pill to take: the informed user should be the chooser. Br Med J 1995; 311: 1111-1112.
10. 10 Editorial. Whipping up panic about the pill. Nature 1995; 377: 663.
11. 11 Weiss N. Third-generation oral contraceptives: how risky? Lancet 1995; 346: 1570.
12. 12 Farmer RDT, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83-88.
13. 13 Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991; 302: 766-768.
14. 14 Van Staa T, Abenheim L. The quality of information on a UK Database of Primary Care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety 1994; 3: 15-21.
15. 15 Petitti DB, Wingerd J, Pellegrin F, Ramcharan S. Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease. Am J Epidemiology 1978; 108: 480-485.
16. 16 Porter JB, Hunter JR, Danileson DA, Jick H, Stergachis A. Oral contraceptives and nonfatal vascular disease - Recent experience. Obstetrics Gynaecol 1982; 59: 299-302.
17. 17 Porter JB, Hunter JR, Jick H, Stergachis A. Oral contraceptives and nonfatal vascular disease. Obstetrics Gynaecol 1985; 66: 1-4.
18. 18 Gerstman BB, Piper JM, Freiman JP, et al. Oral contraceptive oestrogen and progestin potencies and the incidence of deep vein thromboembolism. Int Epidemiol 1990; 19: 931.
19. 19 Jick H, Jick SS, Myers MW, Vasilakis C. Third generation oral contraceptives and venous thrombosis. (Letter). Lancet 1997; 349: 742.